Reappearance of inhibitor in a tolerized patient with severe haemophilia A during FVIII-free emicizumab therapy

Haemophilia. 2021 Jul;27(4):e581-e584. doi: 10.1111/hae.14334. Epub 2021 May 18.
No abstract available

Keywords: FVIII inhibitor; emicizumab; haemophilia A; immune tolerance induction.

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antibodies, Bispecific* / therapeutic use
  • Antibodies, Monoclonal, Humanized* / therapeutic use
  • Factor VIII
  • Hemophilia A* / drug therapy
  • Humans
  • Male

Substances

  • Antibodies, Bispecific
  • Antibodies, Monoclonal, Humanized
  • emicizumab
  • Factor VIII